AI’s prowess predicts lung cancer risk in non-smokers through routine chest X-rays. The study unveils an advanced “CXR-Lung-Risk” model, identifying 28% of participants at significantly higher risk. Dr. Lu emphasizes its pivotal role amid…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Color Health have announced a new program to provide free lung cancer screening access to eligible individuals.
– The program will make it easy for…
Continue Reading
Lunit deploys AI CXR solution to military units in South Korea, PhillippinesLunit, a provider of AI diagnostic support solutions, continues to supply its AI-powered chest x-ray screening solution to military health institutions across Asia-Pacific.
Recently, the…
Researchers at the Wyss Institute at Harvard University have developed a microfluidic chip that can recreate some of the features of radiation-induced lung injury. The lungs are very sensitive to radiation, and this can…
Continue Reading
Sixty four trusts are to get a share of a £21m AI Diagnostic Fund that has been allocated to roll out artificial intelligence (AI) tools to help speed up the diagnosis and treatment of…
Continue Reading
What You Should Know:
– United Therapeutics Corporation and Miromatrix Medical Inc. announced today a definitive agreement for United Therapeutics to acquire Miromatrix for $91M.
– The acquisition of Miromatrix will expand United Therapeutics’ existing complementary…
Continue Reading
Lunit SCOPE IO, driven by AI, achieved a groundbreaking success in a phase III trial for NSCLC patients with EGFR or ALK mutations, published in the Journal of Clinical Oncology. This marks a pivotal…
Continue Reading
DeepTek.ai has achieved FDA clearance for its pioneering Chest X-ray AI solution, the CXR Analyzer, marking a significant milestone. This advanced technology employs deep learning algorithms to automatically detect and categorize abnormalities in chest…
Continue Reading
GE HealthCare has secured a $44 million contract with BARDA to develop AI-driven point-of-care ultrasound technology, aiding clinicians in diagnosing lung pathologies and traumatic injuries during mass casualty events. The collaboration with BARDA aims…
Continue Reading
GE HealthCare announced it signed a $44 million contract with the Biomedical Advanced Research and Development Authority (BARDA) to develop AI-enabled point-of-care ultrasound technology to help clinicians diagnose and treat lung pathologies and traumatic…
Continue Reading
